Involvement of endogenous prostaglandins in ischemic preconditioning in pigs

被引:28
作者
Gres, P [1 ]
Schulz, R [1 ]
Jansen, J [1 ]
Umschlag, C [1 ]
Heusch, G [1 ]
机构
[1] Univ Klinikum Essen, Abt Pathophysiol, Zentrum Innere Med, D-45122 Essen, Germany
关键词
ischemia; preconditioning; prostaglandins; reperfusion;
D O I
10.1016/S0008-6363(01)00505-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In pigs, the infarct size (IS) reduction achieved by a strong preconditioning stimulus (IPs) of 10 min ischemia and 15 min reperfusion is greater than that by a weaker preconditioning stimulus (lPw) of 3 min ischemia and 15 min reperfusion. The cardioprotection achieved by IPw is completely abolished by blockade of bradykinin-B-2-receptors. Since activation of bradykinin-B-2-receptors subsequently activates cyclooxygenase, we now tested whether or not inhibition of cyclooxygenase with indomethacin interferes, with IS reduction by IP. Methods and results: In 42 enflurane-anesthetized pigs, the LAD coronary artery was cannulated, and subendocardial blood flow (ENDO, microspheres, ml/min/g) and IS (%, TTC-staining) were determined. Following 90 min ischemia and 1210 min reperfusion, IS averaged 25.5+/-3.8 (S.E.M.) (ENDO: 0.05+/-0.01). IS was reduced by IPw to 6.3.+/-2.1 (ENDO: 0.07+/-0.01) and further reduced by IPs to 2.4+/-1.0 (ENDO: 0.06+/-0.01). Indomethacin (10 mg/kg i.v.) did not alter IS per se (20.9+/-5.4, ENDO: 0.06+/-0.02), but completely abolished the IS reduction by IPw (23.2+/-5.9, ENDO: 0.06+/-0.01). In contrast, indomethacin abolished the IS reduction by IPs in only two of seven pigs (16.1+/-7.4, ENDO: 0.05+/-0.01). Conclusion: Prostaglandins are involved in IP. However, with stronger IP stimuli other triggers/ mediators can compensate for the lack of prostaglandins. (C) 2002 Elsevier Science BY. All rights reserved.
引用
收藏
页码:626 / 632
页数:7
相关论文
共 32 条
[1]  
Arad M, 1996, MOL CELL BIOCHEM, V161, P249
[2]   Inconsistent relation of MAPK activation to infarct size reduction by ischemic preconditioning in pigs [J].
Behrends, M ;
Schulz, R ;
Post, H ;
Alexandrov, A ;
Belosjorow, S ;
Michel, MC ;
Heusch, G .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (03) :H1111-H1119
[3]   Participation of prostaglandin E2 in the endothelial protective effect of ischaemic preconditioning in isolated rat heart [J].
Bouchard, JF ;
Chouinard, J ;
Lamontagne, D .
CARDIOVASCULAR RESEARCH, 2000, 45 (02) :418-427
[4]   ATTENUATION OF MYOCARDIAL STUNNING BY THE ACE-INHIBITOR RAMIPRILAT THROUGH A SIGNAL CASCADE OF BRADYKININ AND PROSTAGLANDINS BUT NOT NITRIC-OXIDE [J].
EHRING, T ;
BAUMGART, D ;
KRAJCAR, M ;
HUMMELGEN, M ;
KOMPA, S ;
HEUSCH, G .
CIRCULATION, 1994, 90 (03) :1368-1385
[5]   The protective effect of Iloprost, a PGL2-analogue, on ultrastructure of ischemic and reperfused myocardial myocytes [J].
Fitzl, G ;
Winkler, D ;
Wassilev, G ;
Welt, K .
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 1999, 51 (01) :81-88
[6]   ROLE OF BRADYKININ IN PROTECTION OF ISCHEMIC PRECONDITIONING IN RABBIT HEARTS [J].
GOTO, M ;
LIU, YG ;
YANG, XM ;
ARDELL, JL ;
COHEN, MV ;
DOWNEY, JM .
CIRCULATION RESEARCH, 1995, 77 (03) :611-621
[7]   Endogenous protective mechanisms in myocardial ischemia: Hibernation adn ischemic preconditioning [J].
Heusch, G ;
Schulz, R .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (3A) :A26-A33
[8]   Endogenous nitric oxide and myocardial adaptation to ischemia [J].
Heusch, G ;
Post, H ;
Michel, MC ;
Kelm, M ;
Schulz, R .
CIRCULATION RESEARCH, 2000, 87 (02) :146-152
[9]   Nitroglycerin and delayed preconditioning in humans yet another new mechanism for an old drug? [J].
Heusch, G .
CIRCULATION, 2001, 103 (24) :2876-2878
[10]   REDUCTION BY PROSTAGLANDIN-E(1) OR PROSTAGLANDIN-E(0) OF MYOCARDIAL INFARCT SIZE IN THE RABBIT BY ACTIVATION OF ATP-SENSITIVE POTASSIUM CHANNELS [J].
HIDE, EJ ;
NEY, P ;
PIPER, J ;
THIEMERMANN, C ;
VANE, JR .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (05) :2435-2440